HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.

Abstract
Epidemiological and experimental evidence has shown that psychological stress can propel cancer progression. However, its role in anti-angiogenic therapy is not well understood. We previously found that exogenous norepinephrine attenuated the effect of sunitinib, a multi-targeted anti-angiogenic agent, in a mouse melanoma model. Here, we further evaluated the effects of chronic stress on sunitinib therapy in colorectal cancer models. We found that chronic restraint stress markedly weakened the efficacy of sunitinib, primarily through promoting the expression of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) to stimulate tumor angiogenesis in vivo. This effect could be sufficiently mimicked by exogenous norepinephrine and blocked by the β-antagonist propranolol. In vitro, norepinephrine up-regulated expression of VEGF and IL-8 in sunitinib-treated cancer cells mainly through the β-adrenoceptor-cAMP-PKA signaling pathway. Norepinephrine also abrogated sunitinib-induced inhibition of cancer cell migration, but had no effect on direct anti-proliferative activity of sunitinib on cancer cells. These findings suggest that psychological stress might attenuate anti-angiogenic therapy primarily through activating beta-adrenergic signaling to promote tumor angiogenesis. It is also suggested that β-blockers might improve anti-angiogenic outcome under psychological stress.
AuthorsJie Liu, Guo-Hua Deng, Jie Zhang, Ying Wang, Xiang-Yu Xia, Xin-Mei Luo, Yao-Tiao Deng, Sha-Sha He, Yin-Yan Mao, Xing-Chen Peng, Yu-Quan Wei, Yu Jiang
JournalPsychoneuroendocrinology (Psychoneuroendocrinology) Vol. 52 Pg. 130-42 (Feb 2015) ISSN: 1873-3360 [Electronic] England
PMID25437118 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Adrenergic alpha-Agonists
  • Angiogenesis Inhibitors
  • CXCL8 protein, human
  • Indoles
  • Interleukin-8
  • Pyrroles
  • Receptors, Adrenergic, beta
  • Vascular Endothelial Growth Factor A
  • Sunitinib
  • Norepinephrine
Topics
  • Adrenergic alpha-Agonists (metabolism)
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Cell Line, Tumor
  • Chronic Disease
  • Colorectal Neoplasms (drug therapy, metabolism)
  • Disease Models, Animal
  • Female
  • Humans
  • Indoles (pharmacology)
  • Interleukin-8 (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Norepinephrine (metabolism)
  • Pyrroles (pharmacology)
  • Receptors, Adrenergic, beta (metabolism)
  • Signal Transduction
  • Stress, Psychological
  • Sunitinib
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: